Barbara J. Schwarzentraub Power - 02 Jun 2025 Form 4 Insider Report for CONMED Corp (CNMD)

Role: Director
Signature: /s/ Thomas Fistek for Barbara J. Schwarzentraub by Power of Attorney
Issuer symbol: CNMD
Transactions as of: 02 Jun 2025
Net transactions value: $0
Form type: 4
Filing time: 04 Jun 2025, 17:42:25 UTC
Previous filing: 04 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Schwarzentraub Barbara J	Director	C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO	/s/ Thomas Fistek for Barbara J. Schwarzentraub by Power of Attorney	04 Jun 2025	0001788466

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CNMD	Common Stock	Options Exercise	$0	+479	+12%	$0.000000	4,344	03 Jun 2025	Direct
holding	CNMD	Common Stock						1,442	02 Jun 2025	by The Barbara J. Schwarzentraub Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CNMD	Options To Purchase Common Stock	Award	$0	+8,061		$0.000000	8,061	02 Jun 2025	Common Stock	8,061	$55.38	Direct	F1
transaction	CNMD	RSUs (Restricted Stock Units)	Award	$0	+668		$0.000000	668	02 Jun 2025	Common Stock	668	$0.000000	Direct	F2
transaction	CNMD	RSUs (Restricted Stock Units)	Options Exercise	$0	-479	-100%	$0.000000	0	03 Jun 2025	Common Stock	479	$0.000000	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The stock options were granted under the Company's 2025 Long-Term Incentive Plan and generally vest 100% after a one year period.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.
F3	Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period with the RSU vesting immediately upon termination of the Director's service.